Wild-type amyloid beta 1-40 peptide induces vascular smooth muscle cell death independently from matrix

Régis Blaise1, Véronique Mateo, Clotilde Rouxel

  • 1University Paris 6, UR4, Vieillissement, Stress et Inflammation 7 quai Saint-Bernard, 75252 Paris, France.

Aging Cell
|January 21, 2012
PubMed

Insights

Cerebral amyloid angiopathy (CAA) involves amyloid-β (Aβ) peptide damaging brain blood vessels. This study shows matrix metalloprotease (MMP) activity is not involved in the degeneration of vascular smooth muscle cells in sporadic CAA.

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Biochemistry

Background:

  • Cerebral amyloid angiopathy (CAA) is a leading cause of stroke in the elderly, linked to amyloid-β (Aβ) peptide accumulation in brain blood vessels.
  • Aβ deposition impairs vascular smooth muscle cell (VSMC) adhesion to the extracellular matrix (ECM), causing degeneration and vessel wall instability, leading to microhemorrhages and ischemia.
  • The precise molecular mechanisms driving VSMC degeneration in sporadic CAA remain incompletely understood.

Purpose of the Study:

  • To investigate the role of matrix metalloproteinase (MMP)-2 activation in wild-type Aβ(1-40)-induced VSMC degeneration.
  • To determine if MMP activity contributes to VSMC apoptosis in the context of sporadic CAA.

Main Methods:

  • Treatment of VSMCs with wild-type Aβ(1-40) peptide.
  • Assessment of MMP-2 activation pathways, including membrane type1-MMP and tissue inhibitors of MMPs-2 (TIMP-2).
  • Evaluation of VSMC apoptosis using broad-range MMP inhibitors (GM6001, Batimastat) and by modulating MMP-2 activity and expression.

Main Results:

  • Wild-type Aβ(1-40) induced VSMC apoptosis, but MMP activity was not involved in this degenerative process.
  • Inhibition of MMP-2 activation, expression, or activity did not reduce WT-Aβ(1-40)-induced VSMC death.
  • These findings contrast with studies on the Dutch familial form of CAA, suggesting different pathogenic mechanisms.

Conclusions:

  • Matrix metalloproteinase activity is not a key factor in the degeneration of vascular smooth muscle cells in sporadic cerebral amyloid angiopathy.
  • The pathogenesis of sporadic CAA differs from the Dutch familial form, with ECM degradation and VSMC degeneration being independent processes in the sporadic type.